Tissue Microarray

Tissue Microarray (TMA) is an advanced technology that revolutionizes tissue-based research by allowing multiple tissue samples to be analyzed simultaneously on a single slide. By embedding small core biopsies from different specimens into a single paraffin block, human TMAs enable high-throughput analysis, making it easier and more efficient to study biomarkers, disease progression, and therapeutic targets across multiple cases in a standardized manner.

Our Tissue Microarrays

At MYmAb Biologics, we provide expertly developed human tissue microarrays designed to meet the rigorous demands of cancer and pathology research. Our TMAs are carefully constructed using clinically validated samples covering a diverse range of cancer types, disease stages, and histological variations. With a commitment to precision and quality, our TMAs deliver reliable, reproducible results that enhance scientific discoveries and accelerate translational research.

  • Bladder Tumour Tissue Microarray (57 cases) - TBL001

    Bladder Tumour Tissue Microarray (57 cases) – TBL001

    Read more
  • Breast Tumor & Adjacent Normal Tissue Microarray - MB006

    Breast Tumor & Adjacent Normal Tissue Microarray – MB006

    Read more
  • Breast Tumor Tissue Microarray (120 cases) - MBB4

    Breast Tumor Tissue Microarray (120 cases) – MBB4

    Read more
  • Breast Tumor Tissue Microarray (129 cases) - MBB1

    Breast Tumor Tissue Microarray (129 cases) – MBB1

    Read more
  • Breast Tumor Tissue Microarray (131 cases) - MBB3

    Breast Tumor Tissue Microarray (131 cases) – MBB3

    Read more
  • Breast Tumor Tissue Microarray (88 cases) - MBB2

    Breast Tumor Tissue Microarray (88 cases) – MBB2

    Read more
  • Cervical Tumor Tissue Microarray TCE001

    Cervical Tumor Tissue Microarray (60 cases) – TCE001

    Read more
  • Colorectal Tumor Tissue Microarray (29 cases) - MC001

    Colorectal Tumor Tissue Microarray (29 cases) – MC001

    Read more
  • Colorectal Tumor Tissue Microarray (53 cases) – TC003

    Colorectal Tumor Tissue Microarray (53 cases) – TC003

    Read more
  • DCIS Breast Cancer Tissue Microarray (32 cases) - MBB5

    DCIS Breast Cancer Tissue Microarray (32 cases) – MBB5

    Read more

Benefits of Tissue Microarrays

Tissue microarrays offer numerous advantages for researchers seeking efficient, large-scale tissue analysis:

  • High Efficiency: Analyze multiple samples simultaneously, saving time and laboratory resources.
  • Cost-Effective: Reduce reagent and consumable usage compared to traditional slide-based studies.
  • Standardized Data: Maintain consistency across experiments with uniform sample processing.
  • Broad Sample Representation: Study diverse tissue types, cancer subtypes, and patient demographics in one microarray.
  • Custom Solutions: Tailor TMAs to specific research needs, ensuring relevant and focused analysis.

Applications of Human TMAs in Cancer Research

  • Biomarker Discovery & Validation: Identify and confirm new diagnostic and prognostic markers.
  • Drug Development & Screening: Assess treatment responses across different tissue samples.
  • Histopathological & Morphological Studies: Examine tumor characteristics and disease progression.
  • Molecular Profiling: Conduct large-scale genomic, transcriptomic, and proteomic studies.
  • Precision Medicine Research: Support personalized treatment strategies by analyzing patient-specific tissue characteristics.

Why Choose Our Tissue Microarrays

MYmAb Biologics ethically produces human tissue microarrays (TMAs) through our ArrayZeal platform, guided by strict ethical standards and built on a foundation of precision and reliability. Each TMA is carefully constructed using clinically validated human tissue samples sourced from diverse Southeast Asian populations. This ensure better representation of ethic genetic variability, which is an important factor that influences disease progression and treatment responses. Committed to delivering reliable and reproducible results, ArrayZeal support robust scientific discoveries and accelerate translational research. By offering Southeast Asian-derived TMAs, we empower researchers to explore novel therapies within a broader genetic context, paving the way for groundbreaking discoveries and personalized medicine.

Frequently Asked Questions

Conventionally, immunohistochemical staining has been performed on whole tissue sections. However, this traditional method, which requires the processing and staining of hundreds or even thousands of slides, is time-consuming and expensive. In contrast, a TMA allows simultaneous analysis of hundreds of tissues in one go using identical conditions. Thus, TMA technology markedly conserves reagents, saves time and greatly decreases the amount of archival tissue required for a particular study, thus preserving the tissues for other diagnostic and/or research needs.

A core size of 0.6 to 2.0 mm is adequate to represent the whole tissue section.

Sometimes, a small core of sample may not be representative of the whole tumour, especially in heterogenous tumour types. To overcome this, we offer TMAs that include two to three cores of samples from different locations of a single tumour block.

Negative and positive control TMA slides should be included as they are important in ensuring the validity of the experiment.

A minimum of 3 slides per TMA type to include positive and negative controls.

Yes. You may contact us for further details and discuss on your needs.

The TMAs are sent in ambient temperature.

We recommend you to store your TMA slides at 4°C for not more than a year.

Request for Quote

Location:
Block D-G-8, UPM-MTDC Technology Centre III, Universiti Putra Malaysia, 43400 Serdang, Selangor Darul Ehsan, Malaysia.

Phone:
03-8938 9819

Email:
info.mymab@gmail.com

Contact us form